Fatty liver disease is rising globally. Dr Jayakumar D, senior consultant for Gastroenterology at SP Medifort Hospital, ...
A 45-year-old man from Shimla, had been suffering from chronic liver disease (cirrhosis), a condition where the liver shrinks ...
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark, is up 9% ...
Nuvalent, Inc. has promising drugs, zidesamtinib and NVL-655, targeting NSCLC with encouraging data. Read why NUVL stock is a ...
Researchers report significant progress toward expanding the therapeutic options available for people with non-cancerous blood conditions in five studies presented during the 66th American Society of ...